Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.5M | $3.3M | $73,000 | $0 | — | — | — | — |
| Research & development | $10.0M | $10.5M | $11.9M | $17.1M | $19.6M | $10.9M | $8.2M | $3.7M |
| Operating expenses | $16.8M | $18.1M | $22.3M | $25.3M | $25.8M | $16.6M | $10.9M | $5.6M |
| Operating income | −$9.2M | −$14.7M | −$22.2M | −$25.3M | −$25.8M | −$16.6M | −$10.9M | −$5.6M |
| Operating margin | −122.66% | −440.55% | −30,406.85% | — | — | — | — | — |
| EBITDA | −$8.6M | −$14.1M | −$21.6M | −$24.7M | — | — | — | — |
| EBITDA margin | −114.49% | −422.40% | −29,564.38% | — | — | — | — | — |
| Net income | −$7.7M | −$10.6M | −$22.1M | −$23.2M | −$24.5M | −$15.0M | −$11.2M | −$5.5M |
| Net profit margin | −102.38% | −316.00% | −30,308.22% | — | — | — | — | — |
| Basic EPSper basic share | -$0.02 | -$0.20 | -$0.81 | -$0.98 | -$1.26 | -$0.97 | -$0.81 | -$0.43 |
| Diluted EPSper diluted share | -$1.00 | -$10.00 | -$0.81 | -$0.98 | -$1.26 | -$0.97 | -$0.81 | -$0.43 |
Reported shareholders
Reported holdings Number of shares
| Holder | Shares held |
|---|---|
Mattsson Andreas Holm | 5.52M |
Soegaard Marianne | 3.86M |
TAYTON-MARTIN HELEN KATRINA | 2.29M |
Merck & Co., Inc. | 1.21M |
Prego Roberto | 1.17M |
Schmidt Thomas Frederik | 645.75K |
HOLTUG LARS | 258.03K |
Evaxion A/S | 129.14K |
Wegner Lars Aage Staal | 129.14K |
Ikarian Capital, LLC | 74.7K |
Rathbones Group PLC | 45.72K |
Rono Birgitte | 36.77K |
CITADEL ADVISORS LLC | 36.58K |
RENAISSANCE TECHNOLOGIES LLC | 33.8K |
Annis Gardner Whiting Capital Advisors, LLC | 30K |
J. Safra Sarasin Holding AG | 22.9K |
RHUMBLINE ADVISERS | 21.85K |
JANE STREET GROUP, LLC | 20.58K |
BOOTHBAY FUND MANAGEMENT, LLC | 18.43K |
Stonepine Capital Management, LLC | 17.56K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.